A detailed history of 1620 Investment Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 19,184 shares of PFE stock, worth $505,690. This represents 0.45% of its overall portfolio holdings.

Number of Shares
19,184
Previous 19,329 0.75%
Holding current value
$505,690
Previous $540,000 2.78%
% of portfolio
0.45%
Previous 0.44%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$27.7 - $31.39 $4,016 - $4,551
-145 Reduced 0.75%
19,184 $555,000
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $468,421 - $548,902
18,544 Added 2362.29%
19,329 $540,000
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $461,385 - $529,818
-17,821 Reduced 95.78%
785 $21,000
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $8,100 - $10,521
310 Added 1.69%
18,606 $535,000
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $192 - $225
6 Added 0.03%
18,296 $606,000
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $6,826 - $7,898
189 Added 1.04%
18,290 $670,000
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $1,024 - $1,333
26 Added 0.14%
18,101 $738,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $4,342 - $5,668
104 Added 0.58%
18,075 $926,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $6,301 - $7,692
144 Added 0.81%
17,971 $786,000
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $24,428 - $28,964
525 Added 3.03%
17,827 $935,000
Q4 2021

May 16, 2022

BUY
$41.32 - $61.25 $714,918 - $1.06 Million
17,302 New
17,302 $1.02 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track 1620 Investment Advisors, Inc. Portfolio

Follow 1620 Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1620 Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 1620 Investment Advisors, Inc. with notifications on news.